Gabapentin is FDA-approved for postherpetic neuralgia in adults, for adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy. The dosage and frequency of dosing depend on the condition being treated, the patient s age, and other factors. It is not a federally controlled substance, but multiple states have enacted rules to monitor its use due to concerns. Currently, widespread off-label prescribing has led to inconsistent monitoring and limited awareness of formulation differences. Scientists are also questioning the efficacy and safety of gabapentin. This has resulted in variable state regulations regarding gabapentin. Enhanced clinical knowledge, which promotes safe prescribing, improves patient monitoring, prevents adverse outcomes, and supports regulatory compliance, is crucial for optimizing therapeutic benefits and minimizing risks.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Address:
- 3772 Last Best Pl.
Pricing
CME included with membership · $42–99/yr
| Pharmacist Unlimited Plan | $69/yr |
| Pharmacy Tech Unlimited Plan | $42/yr |
| Physician (MD/DO) Unlimited Plan | $99/yr |
| Physician Assistant Unlimited Plan | $99/yr |
| Individual Course (Pharmacy) | $6.99 |
| Individual Course (Physician/PA, per credit) | $6 |
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Cardiology
- Medical Oncology
- Medical Toxicology
- Neonatal-Perinatal Medicine
- Nephrology
- Neurocritical Care
- Neurodevelopmental Disabilities
- Pain Medicine
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pulmonary Disease
- Rheumatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Surgery
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 2 credits
- MOC · Up to 2 points
- $6.99
-
ReleasedJan 26, 2026
-
Last day to claim creditJan 27, 2029 2 years left
-
Medical Letter, The 1747: New Drugs for Weight and Depression, An Alzheimer’s Blood Test, Risks of Tramadol and Gabapentin, more
-
The Curbsiders +1 The Curbsiders Episode #484: Hotcakes: Vitamin D3, Omega-3 Fatty Acids, and Physical Performance, Gabapentin and Falls, Gepotidacin for UTI, and Intermittent Fasting for Weight Loss
-
TRC Healthcare-NetCE Rumor vs Truth – Gabapentin
